NextPhase Medical Devices: A Leading Class II and III Medical Device Contract Manufacturer
Arterex, a dynamic company in the healthcare industry, has recently completed the acquisition of NextPhase Medical Devices from Kidd & Company. NextPhase is a distinguished class II and III medical device contract manufacturer, specializing in complex electromechanical devices, active implantable devices, and single-use disposables.
Operating in North America, the company offers a wide range of services, including design and engineering, manufacturing and assembly, quality and regulatory support, and efficient supply chain and logistics management. With a strong focus on enabling customers to bring low-to-medium volume complex medical devices to market, NextPhase has earned a reputation for excellence in the industry.
KCO’s Investment Journey in NextPhase
The journey of NextPhase’s growth began in 2015 when KCO initiated its investment in the company through a control investment in Nexcore Technology. Founded by Milton Frank in 1999, Nexcore Technology initially focused on manufacturing complex electromechanical medical devices for medical OEMs.
Following the completion of the initial platform acquisition, KCO strategically appointed Carlo Colesanti as NextPhase’s CEO and James DiVizio as CFO, paving the way for a transformational phase in the company’s history. Over the years, KCO made significant investments and enhancements to the initial platform, augmenting people, processes, and infrastructure for improved capabilities.
A Visionary Move: NextPhase’s Evolution into a Comprehensive Provider
In 2017, a defining moment came for NextPhase when Nexcore Technology acquired Phase 2 Medical Manufacturing and rebranded as NextPhase Medical Devices. This strategic move positioned NextPhase as a comprehensive provider offering design, engineering, development, and manufacturing services for capital equipment and single-use disposable devices. With a customer-centric approach, NextPhase swiftly established itself as a trusted partner to leading and emerging medical device OEMs, expanding its market presence significantly.
Enhancing Capabilities through Strategic Acquisition
In 2021, NextPhase reached another milestone by acquiring Proven Process Medical Devices. This strategic move aimed to further enhance the company’s design and engineering capabilities and acquire specific manufacturing expertise in areas like implantable devices. The acquisition bolstered NextPhase’s ability to cater to diverse customer needs and solidified its position as a leader in the medical device contract manufacturing sector.
NextPhase’s Current Operations
Presently, NextPhase operates efficiently from three state-of-the-art facilities located in New Hampshire, Massachusetts, and Tijuana, Mexico. These strategically placed facilities enable the company to offer its services across North America effectively. With a commitment to excellence and innovation, NextPhase continues to be a preferred choice for medical device manufacturers seeking high-quality solutions and seamless supply chain management.
A Bright Future: Arterex’s Acquisition and Growth Prospects
The recent acquisition of NextPhase Medical Devices by Arterex marks a significant milestone in the company’s growth journey. With access to Arterex’s extensive resources and expertise, NextPhase is poised to embark on a new phase of expansion and innovation. Carlo Colesanti,
CEO of NextPhase, expressed his gratitude for KCO’s support and is excited about the prospects for the company’s future growth. As the industry witnesses continuous advancements in medical devices, NextPhase is well-positioned to make a lasting impact, catering to the evolving needs of its customers and shaping the future of medical device contract manufacturing.